Piao et al. revealed that CD133-expressing HCC cells showed a higher activation of the MAPK/PI3K signaling pathway and lower ROS levels after radiation exposure, whereas results from a mouse transplantation tumor model showed that CD133-expressing HCC cells were resistant to apoptosis and radiation [78]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.